| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |